Blauvelt, A. , Han, G., Tyring, S., Soung, J., Oh, T., Davis, L., Vanoorden, V. and Lebwohl, M. 2021. Mean percent PASI improvement with bimekizumab in patients with moderate to severe plaque psoriasis: Pooled results from four phase 3/3b trials. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s55. DOI:https://doi.org/10.25251/skin.5.supp.55.